Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Maintains Strong Buy on 89bio, Raises Price Target to $53

Author: Benzinga Newsdesk | August 06, 2024 01:11pm
Raymond James analyst Steven Seedhouse maintains 89bio (NASDAQ:ETNB) with a Strong Buy and raises the price target from $50 to $53.

Posted In: ETNB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist